« Back to Record
Borg, C., Thielemans, K. M., Le Cesne, A. L. A., Chung-Scott, V., Lazar, V., Tchounkeu Kuigwa, I., Crépineau, F., Lemoine, F., Bernard, J., Fletcher, J. J., Turhan, A., Terme, M., Blay, J. Y., Spatz, A., Emile, J.-F., Heinrich, M. C., Mécheri, S., Tursz, T., Zitvogel, L., Taieb, J., Ménard, C., Flament, C., Robert, C., Maruyama, K., Wakasugi, H., & Angevin, E. (2004). Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. The Journal of clinical investigation, 114(3), 379-388. doi:10.1172/JCI200421102
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253400



